Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Asia Business Gazette.
Press releases published on May 2, 2025

Bon Natural Life Limited Announces Receipt of Nasdaq Delisting Notifications
XI’AN, China, May 02, 2025 (GLOBE NEWSWIRE) -- Bon Natural Life Limited (Nasdaq: BON) (“BON” or the “Company”), one of the leading bio-ingredient solutions providers in the natural, health and personal care industries, announced today that on April 29, …

XRP News: Buy $XDX Tokens Now Before XenDex Presale Ends Soon, as XRP Market Heats Up
SYDNEY, May 02, 2025 (GLOBE NEWSWIRE) -- As excitement grips the XRP community following recent breakthroughs including ProShares’ XRP Futures ETF approval, Brazil’s XRP Spot ETF rollout, and the SEC’s lawsuit withdrawal, all eyes are now on XenDex, the …

Update on Market Making Arrangements
Reykjavík, May 02, 2025 (GLOBE NEWSWIRE) -- (“Amaroq” or the “Company” or the “Corporation”) Update on Market Making Arrangements TORONTO, ONTARIO – May 02, 2025 – Amaroq Minerals Ltd. (AIM, TSXV, NASDAQ Iceland: AMRQ), an independent mining company with a …

PennantPark Investment Corporation Announces Monthly Distribution of $0.08 per Share
MIAMI, May 02, 2025 (GLOBE NEWSWIRE) -- PennantPark Investment Corporation (the “Company”) (NYSE: PNNT) declares its monthly distribution for May 2025 of $0.08 per share, payable on June 2, 2025 to stockholders of record as of May 15, 2025. The …

Jushi Holdings Inc. Updates Call Time to 4:00 p.m. Eastern Time to Report First Quarter 2025 Financial Results on May 8, 2025
BOCA RATON, Fla., May 02, 2025 (GLOBE NEWSWIRE) -- Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH) (OTCQX: JUSHF), a vertically integrated, multi-state cannabis operator, announced that it expects to report its financial results for the first …

PennantPark Floating Rate Capital Ltd. Announces Monthly Distribution of $0.1025 per Share
MIAMI, May 02, 2025 (GLOBE NEWSWIRE) -- PennantPark Floating Rate Capital Ltd. (the "Company") (NYSE: PFLT) declares its monthly distribution for May 2025 of $0.1025 per share, payable on June 2, 2025 to stockholders of record as of May 15, 2025. The …

Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
NEW YORK, May 02, 2025 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that on May 1, 2025 the Company granted inducement awards to purchase up …

Taitron Announces Quarterly Cash Dividend
LOS ANGELES, May 02, 2025 (GLOBE NEWSWIRE) -- Taitron Components Incorporated (NASDAQ:TAIT) today announced that its Board of Directors has declared a quarterly cash dividend of $0.05 per share of common stock, payable on May 30, 2025 to stockholders of …

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
BOSTON , May 02, 2025 (GLOBE NEWSWIRE) -- Verve Therapeutics, a clinical-stage company developing a new class of genetic medicines for cardiovascular disease, today announced that on April 30, 2025, the company granted equity awards to seven new employees, …

Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)
FOSTER CITY, Calif., May 02, 2025 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, …

NurExone Expands European Engagement with Investor Events in Germany and Switzerland
TORONTO and HAIFA, Israel, May 02, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”), a preclinical-stage biotechnology company pioneering exosome-based therapies for central nervous system …

Greenlight Capital Re, Ltd. Schedules First Quarter 2025 Financial Results and Conference Call
GRAND CAYMAN, Cayman Islands, May 02, 2025 (GLOBE NEWSWIRE) -- Greenlight Capital Re, Ltd. (NASDAQ: GLRE) (the "Company" or "Greenlight Re"), a multiline property and casualty insurer and reinsurer, today announced that it expects to release financial …

Copley Acquisition Corp Announces Closing of $172,500,000 Initial Public Offering
HONG KONG, May 02, 2025 (GLOBE NEWSWIRE) -- Copley Acquisition Corp (NYSE: COPLU) (the “Company”) today announced that it closed its initial public offering of 17,250,000 units, including the issuance of 2,250,000 units as result of the underwriters’ …

Concorde International Group Announces Underwriter’s Full Exercise and Closing of Over-allotment Option
Singapore, May 02, 2025 (GLOBE NEWSWIRE) -- Concorde International Group Ltd. (NASDAQ: CIGL) (“Concorde” or the “Company”), an integrated security services provider that combines physical manpower and innovative technology to deliver effective security …

Cipher Mining Announces April 2025 Operational Update
NEW YORK, May 02, 2025 (GLOBE NEWSWIRE) -- Cipher Mining Inc. (NASDAQ:CIFR) (“Cipher” or the “Company”) today released its unaudited production and operations update for April 2025. Key Highlights Key Metrics April 2025 BTC Mined1 174 BTC Sold 350 BTC …

U.S. Global Investors Announces Third Quarter of Fiscal 2025 Webcast
San Antonio, TX, May 02, 2025 (GLOBE NEWSWIRE) -- U.S. Global Investors, Inc. (Nasdaq: GROW) will host a webcast on Friday, May 9, at 7:30 a.m. Central time to discuss the company’s results for the third quarter of fiscal year 2025. Financial data for the …

Beyond Osteo Under Review: Empower Health Labs Spartan Trick for Bone Health Support Against Osteoporosis
New York, May 02, 2025 (GLOBE NEWSWIRE) -- In This Article, You'll Discover: Why bone health quietly deteriorates with age and how it impacts long-term mobility The key signs and symptoms of osteoporosis that most people overlook How Empower Health Labs …

Iovance Biotherapeutics to Host First Quarter 2025 Financial Results and Corporate Updates Webcast on Thursday, May 8, 2025
SAN CARLOS, Calif., May 02, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with …

Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
SAN DIEGO, May 02, 2025 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to …

Silvercrest Asset Management (SAMG) to Announce First Quarter 2025 Results and Host Investor Conference Call
NEW YORK, May 02, 2025 (GLOBE NEWSWIRE) -- Silvercrest Asset Management Group Inc. (NASDAQ: SAMG) announced today it will host a teleconference at 8:30 am Eastern Time on May 9, 2025, to discuss the company’s financial results for the first quarter ended …